← Leaderboards
Suzanne Oparil
University Of Alabama At Birmingham
$34,839,156
Attributed
$41,830,479
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,830,479 · 9
By mechanism
N01$19,072,194 · 1
R01$15,292,202 · 5
T32$7,426,083 · 1
R13$40,000 · 2
Top collaborators
- Jeff M Szychowski5 shared
- Alan Thevenet N. Tita5 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Renee A. Heffron$19,065,543
- Zdenek Hel$11,247,627
- Jan Novak$14,197,925
- Garciela S Alarcon$29,529
- Jeff M Szychowski$5,329,448
Others in their field
Top investigators on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,558,149
- Judith S. Currier · University Of California Los Angeles$143,001,230
- David M Nathan · Massachusetts Institute Of Technology$141,671,512
- John M Lachin · George Washington University$139,991,329
- Judith S Hochman · New York University School Of Medicine$112,514,057
Research focus
Cardiovascular DiseasesHypertensionBlood PressureParticipantCognitive FunctionRisk FactorsHeart FailureMyocardial InfarctionStrokePrimary OutcomeAgedCessation Of LifeCardiovascular Disorder RiskSiteEstrogensIntervention TrialDementiaPrevention StrategyKidney DiseasesChronic Kidney FailureAge-Associated Memory ImpairmentNational Heart, Lung, And Blood InstituteMorbidity - Disease RateDisease Outcome
Grant awards (54)
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,007,149
R01 · FY2025 · HL
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$1,976,808
R01 · FY2024 · HL
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,046,886
R01 · FY2023 · HL
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,103,237
R01 · FY2022 · HL
Mechanisms of Hypertension and Cardiovascular Diseases$499,594
T32 · FY2022 · HL · contact PI
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)$2,352,905
R01 · FY2021 · HL
Mechanisms of Hypertension and Cardiovascular Diseases$476,300
T32 · FY2021 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$245,280
T32 · FY2020 · HL · contact PI
31st Annual Vascular Biology and Hypertension Symposium$25,000
R13 · FY2020 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$316,163
T32 · FY2019 · HL · contact PI
30th Annual Vascular Biology and Hypertension Symposium$15,000
R13 · FY2019 · HL · contact PI
Mechanisms of Refractory Hypertension$501,146
R01 · FY2018 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$424,497
T32 · FY2018 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$411,213
T32 · FY2017 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$6,687
T32 · FY2017 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$6,383
T32 · FY2017 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$3,701
T32 · FY2017 · HL · contact PI
Systolic Blood Pressure Intervention Trial (SPRINT)$2,167,624
N01 · FY2016 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Disease$399,782
T32 · FY2016 · HL · contact PI
Systolic Blood Pressure Intervention Trial (SPRINT)$2,660,072
N01 · FY2015 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$229,826
T32 · FY2015 · HL · contact PI
SPRINT$2,641,032
N01 · FY2014 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$301,372
T32 · FY2014 · HL · contact PI
SPRINT$2,490,262
N01 · FY2013 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$365,771
T32 · FY2013 · HL · contact PI
SPRINT$739,943
N01 · FY2012 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$365,771
T32 · FY2012 · HL · contact PI
O-GlyNAcylation: Novel Mechanism of Estrogen-Induced Vasoprotection$358,875
R01 · FY2012 · HL · contact PI
O-GlyNAcylation: Novel Mechanism of Estrogen-Induced Vasoprotection$362,500
R01 · FY2011 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$353,245
T32 · FY2011 · HL · contact PI
SPRINT$175,000
N01 · FY2011 · HL · contact PI
SPRINT$7,528,158
N01 · FY2010 · HL · contact PI
O-GlyNAcylation: Novel Mechanism of Estrogen-Induced Vasoprotection$362,500
R01 · FY2010 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$164,173
T32 · FY2010 · HL · contact PI
SPRINT$670,103
N01 · FY2009 · HL · contact PI
O-GlyNAcylation: Novel Mechanism of Estrogen-Induced Vasoprotection$362,500
R01 · FY2009 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$348,077
T32 · FY2009 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$345,239
T32 · FY2008 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$345,239
T32 · FY2007 · HL · contact PI
Estrogen Modulates Injury-Induced Inflammation$343,715
R01 · FY2007 · HL · contact PI
Estrogen Modulates Injury-Induced Inflammation$353,981
R01 · FY2006 · HL · contact PI
Mechanisms of Hypertension and Cardiovascular Diseases$292,489
T32 · FY2006 · HL · contact PI
Estrogen Modulates Injury-Induced Inflammation$362,500
R01 · FY2005 · HL
MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASES$192,941
T32 · FY2005 · HL
Estrogen Modulates Injury-Induced Inflammation$362,500
R01 · FY2004 · HL
Mechanisms of Hypertension and Cardiovascular Diseases$294,150
T32 · FY2004 · HL
ADVENTITIAL RESPONSE TO VASCULAR INJURY: ESTROGEN$358,750
R01 · FY2003 · HL
MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASES$340,880
T32 · FY2003 · HL
ADVENTITIAL RESPONSE TO VASCULAR INJURY: ESTROGEN$358,750
R01 · FY2002 · HL
MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASES$323,174
T32 · FY2002 · HL
ADVENTITIAL RESPONSE TO VASCULAR INJURY: ESTROGEN$358,750
R01 · FY2001 · HL
MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASES$304,616
T32 · FY2001 · HL
ADVENTITIAL RESPONSE TO VASCULAR INJURY: ESTROGEN$358,750
R01 · FY2000 · HL
MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASES$69,520
T32 · FY2000 · HL